NCT01380626
- Conditions
- Alpha-1-antitrypsin-deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
- Locations
-
- Klinikum Berchtesgadener Land Berchtesgaden, Germany
Clinical trial condition
Emphysema
Explore clinical trials studying Emphysema. Study availability and eligibility vary by location and protocol.
80 public trials
14 recruiting studies
Emphysema trial results
Completed
Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
NCT01419158
- Conditions
- Alpha-1 Antitrypsin Deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- National Jewish Medical and Research Center Denver, Colorado, United States
- University of Florida (Gainesville) Gainesville, Florida, United States
- University of Florida (Jacksonville) Jacksonville, Florida, United States
NCT00460096
- Conditions
- Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
- Locations
-
- National Jewish Medical and Research Center Denver, Colorado, United States
- University of Florida School of Medicine Gainesville, Florida, United States
- The University of Texas Health Center at Tyler Tyler, Texas, United States
Active, Not Recruiting
Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
NCT01983241
- Conditions
- Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +14 more
- Locations
-
- Grifols Investigative Site Phoenix, Arizona, United States
- Grifols Investigative Site Gainesville, Florida, United States
- Grifols Investigative Site Leesburg, Florida, United States
- Grifols Investigative Site Miami, Florida, United States
Active, Not Recruiting
Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
NCT06738017
- Conditions
- Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- University of California, San Diego San Diego, California, United States
- Saint Louis University St Louis, Missouri, United States
- Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States
- The Medical University of South Carolina Charleston, South Carolina, United States
Active, Not Recruiting
Alpha-1 Antitrypsin Deficiency Adult Liver Study
NCT02014415
- Conditions
- Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
- Locations
-
- University of California San Diego, California, United States
- Boston University School of Medicine Boston, Massachusetts, United States
- Saint Louis University St Louis, Missouri, United States
Active, Not Recruiting
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
NCT06405633
- Conditions
- Alpha-1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- St. Vincent's Hospital, Melbourne Fitzroy, Victoria, Australia
- Dalhousie University - Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
- Inspiration Research Limited Toronto, Ontario, Canada
- Turku University Hospital Turku, Finland
Active, Not Recruiting
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
NCT05297812
- Conditions
- Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California - Los Angeles Los Angeles, California, United States
- National Jewish Health Denver, Colorado, United States
- University of Chicago Chicago, Illinois, United States
Active, Not Recruiting
An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease
NCT05899673
- Conditions
- Alpha1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- UCSD Altman Clinical and Translational Research Institute La Jolla, California, United States
- Stanford Medicine Outpatient Center Redwood City, California, United States
- UF Clinical and Translational Science Institute Gainesville, Florida, United States
- University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
Active, Not Recruiting
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
NCT07193615
- Conditions
- Alpha-1 Antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
- Locations
-
- Ren Ji Hospital Affiliated to Shanghai Jiao Tong University Shanghai, China